{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T10:58:00Z","timestamp":1781348280480,"version":"3.54.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,13]]},"DOI":"10.7759\/cureus.110771","type":"journal-article","created":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T10:35:34Z","timestamp":1781346934000},"source":"Crossref","is-referenced-by-count":0,"title":["The Gluco-Vascular Injury Axis in Diabetic Cardiovascular Dysfunction: A Narrative Review"],"prefix":"10.7759","author":[{"given":"Mohammad Faraz","family":"Omair","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hrishikesh Bhalchandra","family":"Desle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srinidhi S","family":"Hegde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vaishali K","family":"Chavan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yagnik Prafulchandra","family":"Tank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Himanshu","family":"Jha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.2217\/fca-2018-0045","article-title":"Type-2 diabetes mellitus and cardiovascular disease","volume":"14","author":"Henning RJ","year":"2018","unstructured":"Henning RJ. Type-2 diabetes mellitus and cardiovascular disease. Future Cardiol. 2018, 14:491-509. 10.2217\/fca-2018-0045","journal-title":"Future Cardiol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23073587","article-title":"Pathophysiology and treatment of diabetic cardiomyopathy and heart failure in patients with diabetes mellitus","volume":"23","author":"Nakamura K","year":"2022","unstructured":"Nakamura K, Miyoshi T, Yoshida M, et al.. Pathophysiology and treatment of diabetic cardiomyopathy and heart failure in patients with diabetes mellitus. Int J Mol Sci. 2022, 23:7. 10.3390\/ijms23073587","journal-title":"Int J Mol Sci"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1359255","article-title":"Endothelial dysfunction in vascular complications of diabetes: a comprehensive review of mechanisms and implications","volume":"15","author":"Yang DR","year":"2024","unstructured":"Yang DR, Wang MY, Zhang CL, Wang Y. Endothelial dysfunction in vascular complications of diabetes: a comprehensive review of mechanisms and implications. Front Endocrinol (Lausanne). 2024, 15:1359255. 10.3389\/fendo.2024.1359255","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241310705","article-title":"Endothelial dysfunction in diabetes mellitus: new insights","volume":"24","author":"Dubsky M","year":"2023","unstructured":"Dubsky M, Veleba J, Sojakova D, Marhefkova N, Fejfarova V, Jude EB. Endothelial dysfunction in diabetes mellitus: new insights. Int J Mol Sci. 2023, 24:5. 10.3390\/ijms241310705","journal-title":"Int J Mol Sci"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3390\/antiox10081306","article-title":"Pathophysiological association between diabetes mellitus and endothelial dysfunction","volume":"10","author":"Maruhashi T","year":"2021","unstructured":"Maruhashi T, Higashi Y. Pathophysiological association between diabetes mellitus and endothelial dysfunction. Antioxidants (Basel). 2021, 10:6. 10.3390\/antiox10081306","journal-title":"Antioxidants (Basel)"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-023-01965-7","article-title":"The role of oxidative stress in diabetes mellitus-induced vascular endothelial dysfunction","volume":"22","author":"An Y","year":"2023","unstructured":"An Y, Xu BT, Wan SR, Ma XM, Long Y, Xu Y, Jiang ZZ. The role of oxidative stress in diabetes mellitus-induced vascular endothelial dysfunction. Cardiovasc Diabetol. 2023, 22:237. 10.1186\/s12933-023-01965-7","journal-title":"Cardiovasc Diabetol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-021-01257-y","article-title":"Impact of glycemic control on the association of endothelial dysfunction and coronary artery disease in patients with type 2 diabetes mellitus","volume":"20","author":"Chen S","year":"2021","unstructured":"Chen S, Shen Y, Liu YH, et al.. Impact of glycemic control on the association of endothelial dysfunction and coronary artery disease in patients with type 2 diabetes mellitus. Cardiovasc Diabetol. 2021, 20:64. 10.1186\/s12933-021-01257-y","journal-title":"Cardiovasc Diabetol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10092274","article-title":"Coronary microvascular dysfunction in diabetes mellitus: pathogenetic mechanisms and potential therapeutic options","volume":"10","author":"Salvatore T","year":"2022","unstructured":"Salvatore T, Galiero R, Caturano A, et al.. Coronary microvascular dysfunction in diabetes mellitus: pathogenetic mechanisms and potential therapeutic options. Biomedicines. 2022, 10:4. 10.3390\/biomedicines10092274","journal-title":"Biomedicines"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1186\/s12872-018-0770-z","article-title":"Epicardial adipose tissue is related to arterial stiffness and inflammation in patients with cardiovascular disease and type 2 diabetes","volume":"18","author":"Al-Talabany S","year":"2018","unstructured":"Al-Talabany S, Mordi I, Graeme Houston J, et al.. Epicardial adipose tissue is related to arterial stiffness and inflammation in patients with cardiovascular disease and type 2 diabetes. BMC Cardiovasc Disord. 2018, 18:31. 10.1186\/s12872-018-0770-z","journal-title":"BMC Cardiovasc Disord"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.851941","article-title":"Endothelial dysfunction and diabetic cardiomyopathy","volume":"13","author":"Wang M","year":"2022","unstructured":"Wang M, Li Y, Li S, Lv J. Endothelial dysfunction and diabetic cardiomyopathy. Front Endocrinol (Lausanne). 2022, 13:851941. 10.3389\/fendo.2022.851941","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10163682","article-title":"Diabetes mellitus and heart failure","volume":"10","author":"Triposkiadis F","year":"2021","unstructured":"Triposkiadis F, Xanthopoulos A, Bargiota A, et al.. Diabetes mellitus and heart failure. J Clin Med. 2021, 10:2. 10.3390\/jcm10163682","journal-title":"J Clin Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.pcad.2019.07.003","article-title":"Diabetes, heart failure, and renal dysfunction: the vicious circles","volume":"62","author":"Braunwald E","year":"2019","unstructured":"Braunwald E. Diabetes, heart failure, and renal dysfunction: the vicious circles. Prog Cardiovasc Dis. 2019, 62:298-302. 10.1016\/j.pcad.2019.07.003","journal-title":"Prog Cardiovasc Dis"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3390\/cells10020314","article-title":"NLRP3 inflammasome at the interface of inflammation, endothelial dysfunction, and type 2 diabetes","volume":"10","author":"Gora IM","year":"2021","unstructured":"Gora IM, Ciechanowska A, Ladyzynski P. NLRP3 inflammasome at the interface of inflammation, endothelial dysfunction, and type 2 diabetes. Cells. 2021, 10:4. 10.3390\/cells10020314","journal-title":"Cells"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24054321","article-title":"Molecular mechanisms and therapeutic implications of endothelial dysfunction in patients with heart failure","volume":"24","author":"Tsigkou V","year":"2023","unstructured":"Tsigkou V, Oikonomou E, Anastasiou A, et al.. Molecular mechanisms and therapeutic implications of endothelial dysfunction in patients with heart failure. Int J Mol Sci. 2023, 24:2. 10.3390\/ijms24054321","journal-title":"Int J Mol Sci"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3390\/antiox11040784","article-title":"Role of oxidative stress in diabetic cardiomyopathy","volume":"11","author":"De Geest B","year":"2022","unstructured":"De Geest B, Mishra M. Role of oxidative stress in diabetic cardiomyopathy. Antioxidants (Basel). 2022, 11:4. 10.3390\/antiox11040784","journal-title":"Antioxidants (Basel)"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.983713","article-title":"Profile of crosstalk between glucose and lipid metabolic disturbance and diabetic cardiomyopathy: inflammation and oxidative stress","volume":"13","author":"Chen MY","year":"2022","unstructured":"Chen MY, Meng XF, Han YP, Yan JL, Xiao C, Qian LB. Profile of crosstalk between glucose and lipid metabolic disturbance and diabetic cardiomyopathy: inflammation and oxidative stress. Front Endocrinol (Lausanne). 2022, 13:983713. 10.3389\/fendo.2022.983713","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25052973","article-title":"New insights into endothelial dysfunction in cardiometabolic diseases: potential mechanisms and clinical implications","volume":"25","author":"Gallo G","year":"2024","unstructured":"Gallo G, Savoia C. New insights into endothelial dysfunction in cardiometabolic diseases: potential mechanisms and clinical implications. Int J Mol Sci. 2024, 25:3. 10.3390\/ijms25052973","journal-title":"Int J Mol Sci"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.111410","article-title":"Galangin attenuates diabetic cardiomyopathy through modulating oxidative stress, inflammation and apoptosis in rats","volume":"138","author":"Abukhalil MH","year":"2021","unstructured":"Abukhalil MH, Althunibat OY, Aladaileh SH, et al.. Galangin attenuates diabetic cardiomyopathy through modulating oxidative stress, inflammation and apoptosis in rats. Biomed Pharmacother. 2021, 138:111410. 10.1016\/j.biopha.2021.111410","journal-title":"Biomed Pharmacother"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2020.153319","article-title":"Isoliquiritigenin attenuates diabetic cardiomyopathy via inhibition of hyperglycemia-induced inflammatory response and oxidative stress","volume":"78","author":"Gu X","year":"2020","unstructured":"Gu X, Shi Y, Chen X, et al.. Isoliquiritigenin attenuates diabetic cardiomyopathy via inhibition of hyperglycemia-induced inflammatory response and oxidative stress. Phytomedicine. 2020, 78:153319. 10.1016\/j.phymed.2020.153319","journal-title":"Phytomedicine"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2022.952445","article-title":"The mechanisms of glycolipid metabolism disorder on vascular injury in type 2 diabetes","volume":"13","author":"Chen X","year":"2022","unstructured":"Chen X, Shi C, Wang Y, et al.. The mechanisms of glycolipid metabolism disorder on vascular injury in type 2 diabetes. Front Physiol. 2022, 13:952445. 10.3389\/fphys.2022.952445","journal-title":"Front Physiol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01400-z","article-title":"Diabetic vascular diseases: molecular mechanisms and therapeutic strategies","volume":"8","author":"Li Y","year":"2023","unstructured":"Li Y, Liu Y, Liu S, et al.. Diabetic vascular diseases: molecular mechanisms and therapeutic strategies. Signal Transduct Target Ther. 2023, 8:152. 10.1038\/s41392-023-01400-z","journal-title":"Signal Transduct Target Ther"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-022-01016-w","article-title":"Common mechanisms underlying diabetic vascular complications: focus on the interaction of metabolic disorders, immuno-inflammation, and endothelial dysfunction","volume":"21","author":"Xue C","year":"2023","unstructured":"Xue C, Chen K, Gao Z, et al.. Common mechanisms underlying diabetic vascular complications: focus on the interaction of metabolic disorders, immuno-inflammation, and endothelial dysfunction. Cell Commun Signal. 2023, 21:298. 10.1186\/s12964-022-01016-w","journal-title":"Cell Commun Signal"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1007\/s12265-023-10470-x","article-title":"Diabetes mellitus to accelerated atherosclerosis: shared cellular and molecular mechanisms in glucose and lipid metabolism","volume":"17","author":"Zhao N","year":"2024","unstructured":"Zhao N, Yu X, Zhu X, Song Y, Gao F, Yu B, Qu A. Diabetes mellitus to accelerated atherosclerosis: shared cellular and molecular mechanisms in glucose and lipid metabolism. J Cardiovasc Transl Res. 2024, 17:133-52. 10.1007\/s12265-023-10470-x","journal-title":"J Cardiovasc Transl Res"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1007\/s00011-018-1129-8","article-title":"Vascular endothelium dysfunction: a conservative target in metabolic disorders","volume":"67","author":"Jamwal S","year":"2018","unstructured":"Jamwal S, Sharma S. Vascular endothelium dysfunction: a conservative target in metabolic disorders. Inflamm Res. 2018, 67:391-405. 10.1007\/s00011-018-1129-8","journal-title":"Inflamm Res"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1007\/s10741-019-09881-3","article-title":"Role of endothelial dysfunction in heart failure","volume":"25","author":"Zuchi C","year":"2020","unstructured":"Zuchi C, Tritto I, Carluccio E, Mattei C, Cattadori G, Ambrosio G. Role of endothelial dysfunction in heart failure. Heart Fail Rev. 2020, 25:21-30. 10.1007\/s10741-019-09881-3","journal-title":"Heart Fail Rev"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.3390\/antiox11061137","article-title":"Activation of AMPK\/miR-181b axis alleviates endothelial dysfunction and vascular inflammation in diabetic mice","volume":"11","author":"Cheng CK","year":"2022","unstructured":"Cheng CK, Shang W, Liu J, et al.. Activation of AMPK\/miR-181b axis alleviates endothelial dysfunction and vascular inflammation in diabetic mice. Antioxidants (Basel). 2022, 11:7. 10.3390\/antiox11061137","journal-title":"Antioxidants (Basel)"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1177\/13872877261444309","article-title":"NOTCH3-R544C mutation drives endothelial dysfunction through inflammation, migration impairment, and lipid dysregulation","author":"Sun R","year":"2026","unstructured":"Sun R, Li W, Liu N, et al.. NOTCH3-R544C mutation drives endothelial dysfunction through inflammation, migration impairment, and lipid dysregulation. J Alzheimers Dis. 2026, 13872877261444309. 10.1177\/13872877261444309","journal-title":"J Alzheimers Dis"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-89834-9","article-title":"Altered endothelial dysfunction-related miRs in plasma from ME\/CFS patients","volume":"11","author":"Blauensteiner J","year":"2021","unstructured":"Blauensteiner J, Bertinat R, Le\u00f3n LE, Riederer M, Sep\u00falveda N, Westermeier F. Altered endothelial dysfunction-related miRs in plasma from ME\/CFS patients. Sci Rep. 2021, 11:10604. 10.1038\/s41598-021-89834-9","journal-title":"Sci Rep"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1007\/s10557-024-07639-0","article-title":"AGE-RAGE axis and cardiovascular diseases: pathophysiologic mechanisms and prospects for clinical applications","volume":"39","author":"Wang B","year":"2025","unstructured":"Wang B, Jiang T, Qi Y, et al.. AGE-RAGE axis and cardiovascular diseases: pathophysiologic mechanisms and prospects for clinical applications. Cardiovasc Drugs Ther. 2025, 39:1489-506. 10.1007\/s10557-024-07639-0","journal-title":"Cardiovasc Drugs Ther"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1007\/s00580-026-03775-1","article-title":"Targeting the AGE-RAGE system as a therapeutic approach for endotheliopathy","volume":"35","author":"Emereonye CF","year":"2026","unstructured":"Emereonye CF, Areloegbe SE, Oladele CA, Akpor OA, Olatunji LA, Alese OO, Olaniyi KS. Targeting the AGE-RAGE system as a therapeutic approach for endotheliopathy. Comp Clin Pathol. 2026, 35:37. 10.1007\/s00580-026-03775-1","journal-title":"Comp Clin Pathol"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.3390\/molecules25235591","article-title":"The development of Maillard reaction, and advanced glycation end product (AGE)-receptor for AGE (RAGE) signaling inhibitors as novel therapeutic strategies for patients with AGE-related diseases","volume":"25","author":"Shen CY","year":"2020","unstructured":"Shen CY, Lu CH, Wu CH, Li KJ, Kuo YM, Hsieh SC, Yu CL. The development of Maillard reaction, and advanced glycation end product (AGE)-receptor for AGE (RAGE) signaling inhibitors as novel therapeutic strategies for patients with AGE-related diseases. Molecules. 2020, 25:9. 10.3390\/molecules25235591","journal-title":"Molecules"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1128872","article-title":"RAGE signaling regulates the progression of diabetic complications","volume":"14","author":"Taguchi K","year":"2023","unstructured":"Taguchi K, Fukami K. RAGE signaling regulates the progression of diabetic complications. Front Pharmacol. 2023, 14:1128872. 10.3389\/fphar.2023.1128872","journal-title":"Front Pharmacol"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2022.102337","article-title":"Cellular redox imbalance on the crossroad between mitochondrial dysfunction, senescence, and proliferation","volume":"53","author":"Bakalova R","year":"2022","unstructured":"Bakalova R, Aoki I, Zhelev Z, Higashi T. Cellular redox imbalance on the crossroad between mitochondrial dysfunction, senescence, and proliferation. Redox Biol. 2022, 53:102337. 10.1016\/j.redox.2022.102337","journal-title":"Redox Biol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.3390\/antiox7010013","article-title":"Reactive oxygen species and mitochondrial dynamics: the yin and yang of mitochondrial dysfunction and cancer progression","volume":"7","author":"Je\u017eek J","year":"2018","unstructured":"Je\u017eek J, Cooper KF, Strich R. Reactive oxygen species and mitochondrial dynamics: the yin and yang of mitochondrial dysfunction and cancer progression. Antioxidants (Basel). 2018, 7:13. 10.3390\/antiox7010013","journal-title":"Antioxidants (Basel)"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2017.12.022","article-title":"Opening of voltage dependent anion channels promotes reactive oxygen species generation, mitochondrial dysfunction and cell death in cancer cells","volume":"148","author":"DeHart DN","year":"2018","unstructured":"DeHart DN, Fang D, Heslop K, Li L, Lemasters JJ, Maldonado EN. Opening of voltage dependent anion channels promotes reactive oxygen species generation, mitochondrial dysfunction and cell death in cancer cells. Biochem Pharmacol. 2018, 148:155-62. 10.1016\/j.bcp.2017.12.022","journal-title":"Biochem Pharmacol"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1007\/s40572-022-00371-7","article-title":"Environmental chemical exposures and mitochondrial dysfunction: a review of recent literature","volume":"9","author":"Reddam A","year":"2022","unstructured":"Reddam A, McLarnan S, Kupsco A. Environmental chemical exposures and mitochondrial dysfunction: a review of recent literature. Curr Environ Health Rep. 2022, 9:631-49. 10.1007\/s40572-022-00371-7","journal-title":"Curr Environ Health Rep"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9082596","article-title":"Mechanisms of mitochondrial dysfunction in lysosomal storage disorders: a review","volume":"9","author":"Stepien KM","year":"2020","unstructured":"Stepien KM, Roncaroli F, Turton N, Hendriksz CJ, Roberts M, Heaton RA, Hargreaves I. Mechanisms of mitochondrial dysfunction in lysosomal storage disorders: a review. J Clin Med. 2020, 9:6. 10.3390\/jcm9082596","journal-title":"J Clin Med"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1016\/j.artere.2021.07.007","article-title":"Role of increased central arterial stiffness in macro and microvascular damage in patients with coronary artery disease","volume":"33","author":"Hidalgo-Santiago JC","year":"2021","unstructured":"Hidalgo-Santiago JC, Oneto-Otero J, Mich\u00e1n-Do\u00f1a A, Gomez-Fern\u00e1ndez P. Role of increased central arterial stiffness in macro and microvascular damage in patients with coronary artery disease. Clin Investig Arterioscler. 2021, 33:224-34. 10.1016\/j.artere.2021.07.007","journal-title":"Clin Investig Arterioscler"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.3390\/jvd4020021","article-title":"Peripheral artery disease: atherosclerosis, decreased nitric oxide, and vascular arterial stiffening","volume":"4","author":"Hayden MR","year":"2025","unstructured":"Hayden MR. Peripheral artery disease: atherosclerosis, decreased nitric oxide, and vascular arterial stiffening. J Vasc Dis. 2025, 4:21. 10.3390\/jvd4020021","journal-title":"J Vasc Dis"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-025-02346-0","article-title":"Arterial stiffness and vascular aging: mechanisms, prevention, and therapy","volume":"10","author":"Herzog MJ","year":"2025","unstructured":"Herzog MJ, M\u00fcller P, Lechner K, et al.. Arterial stiffness and vascular aging: mechanisms, prevention, and therapy. Signal Transduct Target Ther. 2025, 10:282. 10.1038\/s41392-025-02346-0","journal-title":"Signal Transduct Target Ther"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.100396","article-title":"Association of diabetic retinopathy and arterial stiffness with cardiovascular disease in type 2 diabetes","volume":"17","author":"Agapitou C","year":"2025","unstructured":"Agapitou C, Pappelis K, Chatzirallis A, et al.. Association of diabetic retinopathy and arterial stiffness with cardiovascular disease in type 2 diabetes. Cureus. 2025, 17:e100396. 10.7759\/cureus.100396","journal-title":"Cureus"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-019-2051-3","article-title":"Arterial stiffness correlates with progressive nailfold capillary microscopic changes in systemic sclerosis: results from a cross-sectional study","volume":"21","author":"Soulaidopoulos S","year":"2019","unstructured":"Soulaidopoulos S, Pagkopoulou E, Katsiki N, et al.. Arterial stiffness correlates with progressive nailfold capillary microscopic changes in systemic sclerosis: results from a cross-sectional study. Arthritis Res Ther. 2019, 21:253. 10.1186\/s13075-019-2051-3","journal-title":"Arthritis Res Ther"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9092880","article-title":"Coronary microvascular dysfunction","volume":"9","author":"Vancheri F","year":"2020","unstructured":"Vancheri F, Longo G, Vancheri S, Henein M. Coronary microvascular dysfunction. J Clin Med. 2020, 9:8. 10.3390\/jcm9092880","journal-title":"J Clin Med"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1007\/s11239-023-02862-2","article-title":"Molecular mechanisms of endothelial dysfunction in coronary microcirculation dysfunction","volume":"56","author":"Zhang Z","year":"2023","unstructured":"Zhang Z, Li X, He J, Wang S, Wang J, Liu J, Wang Y. Molecular mechanisms of endothelial dysfunction in coronary microcirculation dysfunction. J Thromb Thrombolysis. 2023, 56:388-97. 10.1007\/s11239-023-02862-2","journal-title":"J Thromb Thrombolysis"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1016\/j.vph.2023.107239","article-title":"Pathophysiology of coronary microvascular dysfunction","volume":"153","author":"Crea F","year":"2023","unstructured":"Crea F, Montone RA. Pathophysiology of coronary microvascular dysfunction. Vascul Pharmacol. 2023, 153:107239. 10.1016\/j.vph.2023.107239","journal-title":"Vascul Pharmacol"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2018.02.010","article-title":"Coronary microembolization and microvascular dysfunction","volume":"258","author":"Heusch G","year":"2018","unstructured":"Heusch G, Skyschally A, Kleinbongard P. Coronary microembolization and microvascular dysfunction. Int J Cardiol. 2018, 258:17-23. 10.1016\/j.ijcard.2018.02.010","journal-title":"Int J Cardiol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/496899-the-gluco-vascular-injury-axis-in-diabetic-cardiovascular-dysfunction-a-narrative-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T10:35:35Z","timestamp":1781346935000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/496899-the-gluco-vascular-injury-axis-in-diabetic-cardiovascular-dysfunction-a-narrative-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,13]]},"references-count":46,"URL":"https:\/\/doi.org\/10.7759\/cureus.110771","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6,13]]}}}